Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 4Neoplasms 4Breast Neoplasms 4Hematologic Neoplasms 3Motor Activity 2Colorectal Neoplasms 2Breast Carcinoma In Situ 2Urinary Incontinence 1Urinary Bladder Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parents Who Have Lost a Child to Cancer 1Papillomavirus Infections 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Malignant Female Reproductive System Neoplasm 1Health Behavior 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Endometrial Neoplasms 1Diabetes Mellitus 1Depression 1Coronary Artery Disease 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Cardiovascular Diseases 1Anxiety Disorders 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 34Specimen Handling 18Paclitaxel 16Magnetic Resonance Spectroscopy 15Carboplatin 14Biopsy 14Nivolumab 13Ipilimumab 12Gemcitabine 10Irinotecan 9Radiosurgery 8atezolizumab 7abemaciclib 7Radiation 7Pemetrexed 7Cisplatin 7Capecitabine 7130-nm albumin-bound paclitaxel 7trastuzumab deruxtecan 6olaparib 6durvalumab 6avelumab 6Docetaxel 6osimertinib 5adagrasib 5Trastuzumab 5Fulvestrant 5Cetuximab 5Albumin-Bound Paclitaxel 5palbociclib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasm Metastasis × Interviews as Topic × Clear all
NCT05455606 2026-01-22

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

SWOG Cancer Research Network

Phase NA Active not recruiting
1,284 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡